SLC7A11 and cancer: Thus, inhibition of xCT by sulfasalazine decreases cystine uptake and disrupts GSH production so as to sensitize cancer cells, in this case triple negative breast cancer cells, to treatment with anti-cancer agents that disrupt redox balance (Hasegawa et al., 2016).